Conversely, the addition of LPA attenuated TMP’s inhibitory effect on the RhoA/ROCK pathway, consistent with other studies (Levy et al., 2015), and MAP2, a dendritic plasticity-related protein sensitive to ischemia, were both upregulated by TMP treatment (Li et al., 1998). The gene discussed is MAP2; the disease is ischemia.